<!DOCTYPE sequence-cwu SYSTEM "us-sequence-listing-2004-03-09.dtd" [ ]>
<sequence-cwu id="SEQLST-1">
<publication-reference>
<document-id>
<country>US</country>
<doc-number>08623600</doc-number>
<kind>B2</kind>
<date>20140107</date>
</document-id>
</publication-reference>
<number>1</number>
<sequence-list-new-rules>
<s100>
<s160>10</s160>
</s100>
<s200>
<s210>1</s210>
<s211>5</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Synthetic peptide - MutLa interaction motif in
      human Exo1 and BLM helicase</s223>
</s220>
</s200>
<s400> 1
Arg Ser Xaa Xaa Phe
1               5
</s400>
<s200>
<s210>2</s210>
<s211>5</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Synthetic peptide</s223>
</s220>
</s200>
<s400> 2
Leu Ser Arg Phe Phe
1               5
</s400>
<s200>
<s210>3</s210>
<s211>8</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Synthetic peptide</s223>
</s220>
</s200>
<s400> 3
Gln Ala Val Leu Ser Arg Phe Phe
1               5
</s400>
<s200>
<s210>4</s210>
<s211>21</s211>
<s212>DNA</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Synthetic DNA</s223>
</s220>
</s200>
<s400> 4
ccgctacact tgccagcgcc a                                               21
</s400>
<s200>
<s210>5</s210>
<s211>20</s211>
<s212>DNA</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Synthetic DNA</s223>
</s220>
</s200>
<s400> 5
gttcaaaaaa ccccagctcc                                                 20
</s400>
<s200>
<s210>6</s210>
<s211>8</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Synthetic peptide</s223>
</s220>
</s200>
<s400> 6
Gln Xaa Xaa Xaa Xaa Xaa Phe Phe
1               5
</s400>
<s200>
<s210>7</s210>
<s211>12</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Synthetic peptide</s223>
</s220>
</s200>
<s400> 7
Phe Leu Asn Cys Cys Pro Gly Cys Cys Met Glu Pro
1               5                   10
</s400>
<s200>
<s210>8</s210>
<s211>33</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Synthetic peptide MSH3</s223>
</s220>
</s200>
<s400> 8
Met Ser Arg Arg Lys Pro Ala Ser Gly Gly Leu Ala Ala Ser Ser Ser
1               5                   10                  15
Ala Pro Ala Arg Gln Ala Val Leu Ser Arg Phe Phe Gln Ser Thr Gly
            20                  25                  30
Ser
</s400>
<s200>
<s210>9</s210>
<s211>6</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Synthetic peptide MSH3delta28</s223>
</s220>
</s200>
<s400> 9
Met Gln Ser Thr Gly Ser
1               5
</s400>
<s200>
<s210>10</s210>
<s211>33</s211>
<s212>PRT</s212>
<s213>Artificial Sequence</s213>
<s220>
<s223>Synthetic peptide MSH3-F27A-F28A</s223>
</s220>
</s200>
<s400> 10
Met Ser Arg Arg Lys Pro Ala Ser Gly Gly Leu Ala Ala Ser Ser Ser
1               5                   10                  15
Ala Pro Ala Arg Gln Ala Val Leu Ser Arg Ala Ala Gln Ser Thr Gly
            20                  25                  30
Ser
</s400>
</sequence-list-new-rules>
</sequence-cwu>
